Filter
441
Filtered Results: 441
Text search:
antimicrobial
susceptibility
testing
Featured
Recommendations
61
New Publications
98
Language
Document type
No document type
158
Guidelines
112
Studies & Reports
109
Strategic & Response Plan
27
Manuals
17
Training Material
8
Situation Updates
7
Infographics
1
Online Courses
1
Fact sheets
1
Countries / Regions
India
27
South Africa
16
Ethiopia
14
Kenya
13
Global
9
Africa
9
Western and Central Europe
8
Philippines
7
Nigeria
6
Zimbabwe
6
Latin America and the Carribbean
6
Nepal
5
Malawi
5
Asia
5
Eastern Europe
5
Ukraine
4
Ghana
4
Tanzania
4
Russia
4
Zambia
4
Sierra Leone
3
Cameroon
3
Western Pacific Region
3
Uganda
3
Eswatini/ Swaziland
3
Rwanda
2
Laos
2
Burkina Faso
2
Cambodia
2
Gabon
2
Myanmar / Burma
2
Pakistan
2
Thailand
1
China
1
Albania
1
Fiji
1
Senegal
1
Afghanistan
1
Peru
1
Mozambique
1
USA
1
Jordan
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
East and Southern Africa
1
Lebanon
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Sudan
1
Mali
1
Libya
1
Bhutan
1
Botswana
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
62
Pharmacy & Technologies
17
Public Health
13
Women & Child Health
13
Key Resources
13
Capacity Building
3
Toolboxes
AMR
187
TB
59
HIV
24
Rapid Response
20
Cholera
13
Planetary Health
12
COVID-19
10
NTDs
10
Ebola & Marburg
7
Pharmacy
7
Refugee
6
Mental Health
4
Conflict
4
Caregiver
3
NCDs
3
Natural Hazards
2
Polio
2
Global Health Education
2
Specific Hazards
1
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Standard Operating Procedures for Implementation of TB Activities at HIV/AIDS Service Delivery Sites
Washington, D.C., USA, 23-27 September 2018
Provisional Agenda Item 4.6
CD56/10, Rev. 1 31 August 2018
Original: Spanish
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement...
Accessed at March 2014
Policy framework.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
Ethiopian Medicines Formulary
recommended
2nd edition
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
The Ethiopia Multi-Sectorial Cholera Elimination Plan (2022-2028) outlines a national strategy to eliminate cholera in Ethiopia by 2028. The plan follows the Global Roadmap to End Cholera by 2030 and is based on six key pillars: Leadership & Coordination, Water, Sanitation & Hygiene (WASH), Surveill...
